Diagnostic test (2×2 table)
Assesses diagnostic performance against a reference standard using true/false positive and negative study counts.
Calculate with transparency
Check the population, units and version. The result shows the formula or classification; it does not make an automatic treatment decision.
Preparing the form…
- Check the method
- Enter the data
- Check the result
Method · Limits of application
2×2:sensitivity/specificity/PPV/NPV; Wilson 95% proportions; Simel 1991 logarithmic LR intervals; not Wald proportions
The table requires binary classification of the test and reference status, with consistent counts for the same population. Positive and negative predictive values depend on prevalence and do not transfer automatically to another population. A zero denominator may make a measure undefined. Wilson intervals for proportions and logarithmic intervals for likelihood ratios are different methods; zero counts and small samples require specific interpretation. This analysis alone does not establish the quality of the reference standard or validate the test.
Conditions of use
Check the population, units, inclusion and exclusion criteria, and version in the original source. A result alone does not establish a diagnosis, discharge decision or prescription.
Documented parameters
- True positives (TP): positive test and disease present
- False positives (FP): positive test and no disease
- False negatives (FN): negative test and disease present
- True negatives (TN): negative test and no disease
3/3 reference cases checked. Numerical tests are not clinical validation.
Relationship with cancer research
Support for research — context required
Diagnostic performance measures from study data. They may support the evaluation of cancer tests if the reference standard and sample are appropriate.
Applications: Early detection and risk assessment · Clinical trials and methods
Treatment resistance
A study of 96 patients with epithelial ovarian cancer evaluated the sensitivity and specificity of biomarkers for platinum resistance, defined by the progression-free interval (Gerber et al., 2023). This table supports analysis at a fixed threshold using user-supplied TP/FP/FN/TN counts; it does not measure gelsolin, select a threshold, generate ROC/AUC, or reproduce the study from rounded percentages.